Lamb Kathleen M, DiMuzio Paul J, Johnson Adam, Batista Philip, Moudgill Neil, McCullough Megan, Eisenberg Joshua A, Hirose Hitoshi, Cavarocchi Nicholas C
Division of Vascular and Endovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pa.
Divisions of Cardiothoracic Surgery and Vascular and Endovascular Surgery, Thomas Jefferson University, Philadelphia, Pa.
J Vasc Surg. 2017 Apr;65(4):1074-1079. doi: 10.1016/j.jvs.2016.10.059.
Venoarterial extracorporeal membrane oxygenation (ECMO) is a salvage therapy in patients with severe cardiopulmonary failure. Owing to the large size of the cannulas inserted via the femoral vessels (≤24-F) required for adequate oxygenation, this procedure could result in significant limb ischemic complications (10%-70%). This study evaluates the results of a distal limb perfusion arterial protocol designed to reduce associated complications.
We conducted a retrospective institutional review board-approved review of consecutive patients requiring ECMO via femoral cannulation (July 2010-January 2015). To prevent arterial ischemia, a distal perfusion catheter (DPC) was placed antegrade into the superficial femoral artery and connected to the ECMO circuit. Limb perfusion was monitored via near-infrared spectroscopy (NIRS) placed on both calves. Decannulation involved open repair, patch angioplasty, and femoral thrombectomy as needed.
A total of 91 patients were placed on ECMO via femoral arterial cannula (16-F to 24-F) for a mean duration of 9 days (range, 1-40 days). A percutaneous DPC was inserted prophylactically at the time of cannulation in 55 of 91 patients, without subsequent ischemia. Of the remaining 36 patients without initial DPC placement, 12 (33% without DPC) developed ipsilateral limb ischemia related to arterial insufficiency, as detected by NIRS and clinical findings. In these patients, the placement of a DPC (n = 7) with or without a fasciotomy, or with a fasciotomy alone (n = 4), resulted in limb salvage; only one patient required subsequent amputation. After decannulation (n = 7), no patients had further evidence of limb ischemia. Risk factors for the development of limb ischemia identified by categorical analysis included lack of DPC at time of cannulation and ECMO cannula size of less than 20-Fr. There was a trend toward younger patient age. Overall ECMO survival rate was 42%, whereas survival in patients with limb ischemia was only 25%.
Limb ischemia complications from ECMO may be decreased by prophylactic placement of an antegrade DPC. Without DPC, continuous monitoring using NIRS may identify limb ischemia, which can be treated subsequently with DPC and or fasciotomy.
静脉-动脉体外膜肺氧合(ECMO)是治疗严重心肺功能衰竭患者的一种挽救性治疗方法。由于经股血管插入的用于充分氧合的插管尺寸较大(≤24F),该操作可能导致显著的肢体缺血并发症(10%-70%)。本研究评估旨在减少相关并发症的远端肢体灌注动脉方案的效果。
我们对经机构审查委员会批准的、通过股动脉插管接受ECMO治疗的连续患者(2010年7月至2015年1月)进行了回顾性研究。为预防动脉缺血,将一根远端灌注导管(DPC)顺行置入股浅动脉并连接至ECMO回路。通过置于双侧小腿的近红外光谱(NIRS)监测肢体灌注情况。拔管时根据需要进行开放修复、补片血管成形术和股动脉血栓切除术。
共有91例患者通过股动脉插管(16F至24F)接受ECMO治疗,平均持续时间为9天(范围1至40天)。91例患者中有55例在插管时预防性插入了经皮DPC,随后未发生缺血。其余36例未初始放置DPC的患者中,12例(未放置DPC的患者中占33%)出现了与动脉供血不足相关的同侧肢体缺血,通过NIRS和临床检查发现。在这些患者中,放置DPC(n = 7),无论是否进行筋膜切开术,或仅进行筋膜切开术(n = 4),均成功挽救了肢体;只有1例患者随后需要截肢。拔管后(n = 7),没有患者出现肢体缺血的进一步证据。通过分类分析确定的肢体缺血发生的危险因素包括插管时未放置DPC以及ECMO插管尺寸小于20F。患者年龄较轻有一定趋势。总体ECMO生存率为42%,而肢体缺血患者的生存率仅为25%。
预防性顺行放置DPC可减少ECMO引起的肢体缺血并发症。在未放置DPC的情况下,使用NIRS进行连续监测可识别肢体缺血,随后可通过放置DPC和/或筋膜切开术进行治疗。